Potent VEGF blockade causes regression of coopted vessels in a model of neuroblastoma
Eugene S. Kim(Cedars-Sinai Medical Center), Darrell J. Yamashiro(Morgan Stanley Children's Hospital), Stephanie M. Zabski(Regeneron (United States)), Christina Manley(Regeneron (United States)), Laurence E. Ring(Regeneron (United States)), Jocelyn Holash(Regeneron (United States)), Jessica J. Kandel(Presbyterian College), Samuel Z. Soffer(Regeneron (United States)), Anna Serur, George D. Yancopoulos(Regeneron (United States)), Jianzhong Huang, John S. Rudge(Regeneron (United States)), Jason S. Frischer, Tamara New(Columbia University), Kimberly W. McCrudden(Regeneron (United States))
Cited by 313
Related Papers
Vascular-specific growth factors and blood vessel formation
|Nature|2000|3.7k
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
|New England Journal of Medicine|2016|2k
VEGF-Trap: A VEGF blocker with potent antitumor effects
|Proceedings of the National Academy of Sciences|2002|1.7k
Regulation of the Germinal Center Response by MicroRNA-155
|Science|2007|1.5k
Angiopoietin-1 protects the adult vasculature against plasma leakage
|Nature Medicine|2000|1.3k